Synthesis 2016; 48(14): 2245-2254
DOI: 10.1055/s-0035-1561598
paper
© Georg Thieme Verlag Stuttgart · New York

Synthesis of Novel 3,19-Dihydroxyjolkinolides and Related Derivatives Starting from Andrographolide

Ke Wang
a   Center of Drug Discovery, China Pharmaceutical University, 24 Tongjia Xiang Road, Nanjing 210009, P. R. of China
,
Yang-Chang Wu
b   School of Pharmacy, College of Pharmacy, China Medical University, 91 Hsueh-Shih Road, Taichung 40402, Taiwan, ROC
c   Chinese Medicine Research and Development Center, China Medical University Hospital, Taichung 40447, Taiwan, ROC
,
Juan-Cheng Yang
b   School of Pharmacy, College of Pharmacy, China Medical University, 91 Hsueh-Shih Road, Taichung 40402, Taiwan, ROC
c   Chinese Medicine Research and Development Center, China Medical University Hospital, Taichung 40447, Taiwan, ROC
,
Meng-Han Zhang
a   Center of Drug Discovery, China Pharmaceutical University, 24 Tongjia Xiang Road, Nanjing 210009, P. R. of China
,
Mohamed El-Shazly
d   Department of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, Ain Shams University, Organization of African Unity Street, Abassia, Cairo 11566, Egypt   eMail: zhangdayong@cpu.edu.cn   eMail: xmwu@cpu.edu.cn
,
Da-Yong Zhang*
a   Center of Drug Discovery, China Pharmaceutical University, 24 Tongjia Xiang Road, Nanjing 210009, P. R. of China
,
Xiao-Ming Wu*
a   Center of Drug Discovery, China Pharmaceutical University, 24 Tongjia Xiang Road, Nanjing 210009, P. R. of China
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received: 20. Januar 2016

Accepted after revision: 07. März 2016

Publikationsdatum:
03. Mai 2016 (online)


Preview

Abstract

The jolkinolides are a series of naturally occurring ent-abietane diterpenes with potent antitumor activity, which have been isolated from the genus Euphorbia. We describe the first method for the total synthesis of 3,19-dihydroxyjolkinolide and its derivatives. The strategy for the synthesis of 3,19-dihydroxyjolkinolide A has 12 steps with an overall yield of 4.3%. The synthesized compounds were evaluated for their antitumor activity in nine kinds of tumor cell lines.

Supporting Information